Transcranial Doppler Ultrasound Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Transcranial Doppler Ultrasound Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Transcranial Doppler Ultrasound Market is expected to register a CAGR of 6% during the forecast period.

The COVID-19 pandemic affected healthcare systems globally and resulted in the interruption of usual care in many healthcare facilities, exposing vulnerable patients to significant risks. COVID-19 has impacted the growth of the studied market. For instance, according to an article published in March 2021, titled ‘Transcranial Doppler Ultrasound (TCD) Evidence of Active Cerebral Embolization in COVID-19’, Clinical TCD ultrasonography for the identification of microemboli was performed on patients with confirmed COVID-19 between May and June 2020, in Chicago. It has been observed that three individuals with confirmed COVID-19 and evidence of cerebral artery microemboli were identified using TCD ultrasonography for microemboli identification, one of whom was receiving therapeutic anticoagulation. Thus, TCD ultrasonography offers a non-invasive way to assess cerebral microemboli in COVID-19 patients and can help assess therapy response in cases with suspected or confirmed disorders of hypercoagulability. Hence, COVID-19 has a significant impact on market growth.

Certain factors that are propelling the market growth are the growing preference for transcranial doppler in detecting various cerebrovascular diseases and the rising technological advancements.

The increasing burden of cerebrovascular disease among the population increase the adoption of transcranial doppler ultrasound devices for continuous neuromonitoring is expected to increase the market growth over the forecast period. For instance, according to an article published in April 2022, titled ‘Transcranial Doppler Ultrasonography as a Diagnostic Tool for Cerebrovascular Disorders’, the transcranial doppler (TCD) method of diagnosing cerebrovascular diseases is less expensive, non-invasive, and practically easier than the other imaging techniques. In addition, the transcranial doppler method is considered the most practicable method to monitor vascular alterations in response to therapy for treating cerebrovascular problems such as cerebral sinus venous thrombosis (CSVT), acute ischemic stroke (AIS), intracranial atherosclerotic stenosis (ICAS) and cerebral vasospasm (CV). Furthermore, TCD can detect most lesions amenable to interventional treatment, such as stenting and local thrombolysis as well as angioplasty, as well as monitor the impact of the underlined interventions. Thus, the increasing applications of TCD in detecting as well as monitoring various cerebrovascular diseases are expected to increase its adoption, thereby fueling market growth.

Similarly, as per an article published in September 2021, titled ‘Transcranial Doppler ultrasonography (uses, limitations, and potentials): a review article’, it has been observed that TCD as a non-invasive easily available at the bedside, the radiation-free device can help prevent the neurologic deficits in critically ill patients with ischemic stroke, subarachnoid hemorrhage (SAH), and traumatic brain injury (TBI) who have cerebral hemodynamic disturbances, who require extended neuromonitoring. This is expected to boost the demand for transcranial doppler ultrasound, thereby bolstering market growth.

Furthermore, according to the data published by the Centers for Disease Control and Prevention, in December 2021, titled “Concussions and Brain Injuries in Children: the United States, 2020”, it has been observed that about 6.8 percent of children aged 17 and under had experienced a concussion or brain injury symptoms, in 2020. In addition, as per the same source, the percentage of children who had ever experienced concussion or brain injury symptoms increased with age, rising from 2.0 percent in children aged 5 to 12.2 percent in children aged 12 to 17. Thus, traumatic brain injuries alter cerebrovascular function by causing long-term neurodegeneration, poor autoregulation, subarachnoid hemorrhage, vasospasms, edema, and disruption of the blood-brain barrier, which is expected to increase the demand for extended neuromonitoring, thereby propelling the market growth.

However, the lack of skilled expertise in handling the ultrasound system is expected to restrain the market growth over the forecast period.

Key Market TrendsSickle Cell Diseases Segment Expects to Register a High CAGR in the Transcranial Doppler Ultrasound Market Over the Forecast Period

The sickle cell disease segment is expected to witness significant growth in the transcranial doppler ultrasound market over the forecast period owing to the increasing burden of sickle cell anemia, and its effects on the cerebral blood flow, among the population and the rising application of intracranial doppler ultrasound system in patients with sickle cell disease.

The rising prevalence of sickle cell disease is the key factor driving the demand for transcranial doppler ultrasound. For instance, according to the 2022 statistics published by the Centers for Disease Control and Prevention, approximately 100,000 Americans are affected by sickle cell disease every year. In addition, about 300,000 babies are born every year with sickle cell anemia, worldwide and this number is expected to double in near future. Thus, the high burden of sickle cell disease among the population is expected to increase the market growth over the forecast period.

Additionally, according to an article published in April 2021, titled ‘Impairment of Cerebrovascular Hemodynamics in Patients with Severe and Milder Forms of Sickle Cell Disease’, it has been observed that in sickle cell disease (SCD) patients, cerebral blood flow (CBF) is increased to combat anemia and maintain the brain's oxygen supply constant. This could deplete the arteries' ability to dilate, potentially raising the risk of silent cerebral infarctions. Thus, the high risk of cerebral infarctions is expected to increase the demand for transcranial doppler ultrasound devices to detect as well as monitor the patient’s condition, thereby propelling market growth.

Thus, owing to the aforementioned factors, the studied market is expected to grow over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period

North America is expected to hold a major market share in the global transcranial doppler ultrasound system market over the forecast period owing to the factors such as the rising incidences of neurological disorders and the increasing geriatric population, as these populations need a constant diagnosis to be done.

Moreover, high healthcare spending, the presence of well-established healthcare infrastructure, the increasing rate of cardiovascular diseases, and brain injuries that affect the blood flow in the brain are also contributing to the market growth.

The high burden of neurovascular or cerebrovascular diseases in the United States is expected to be the major driving factor for the growth of the transcranial doppler ultrasound market over the forecast period. For instance, according to the April 2022 update of the Centers for Disease Control and Prevention (CDC), about 795,000 cases of stroke are reported in the United States every year, of which 610,000 are first or new strokes and further, of all reported cases of stroke, approximately 87% are ischemic strokes in which blood flow to the brain is blocked. Additionally, as per January 2022 update from the Centers for Disease Control and Prevention (CDC), stroke or cerebrovascular disease is one of the major health concerns in the United States with about 2.2 million visits to physicians' offices with stroke as a primary diagnosis and there were about 7.8 million adults who ever had a stroke in the country. Similarly, according to the data published by Canadian Institute for Health Information, in July 2021, more than 62,000 strokes occur each year in Canada, making it the third most common cause of death. Thus, owing to the high burden of stroke in the country, the studied market is expected to grow over the forecast period.

In addition, according to the Organization for Economic Co-operation and Development (OECD), in June 2022, United States healthcare spending in 2021 was 17.8% of the total GDP of the country and Mexico’s health spending as a share of GDP was 6.2% in 2020, This is expected to positively impact market growth. Additionally, as per the Centers for Medicare and Medicaid Services, National Health spending is projected to grow at an average annual rate of 5.4% for 2019-2028 and to reach USD 6.2 trillion by 2028. As national health expenditure is projected to grow 1.1% points faster than gross domestic product per year on average over 2019-2028 the health share of the economy is projected to rise by 19.7% in 2028. Also, Medicare covers approximately 72% of all patients with stroke and approximately 75% of the total stroke cost in the United States. Thus, the increasing healthcare spending is expected to increase company activities in developing effective and technologically advanced transcranial doppler ultrasound systems, thereby propelling the market growth.

Furthermore, the rising company activities in developing technologically advanced ultrasound system for monitoring and detecting cerebrovascular disease is also contributing to the market growth. For instance, in February 2021, Novasignal Corp launched a cloud-based app to provide alerts to clinicians directly from its cerebral ultrasound device. The app allows physicians to get instant notifications from the company’s Novaguide device, a transcranial doppler ultrasound technology that allows for real-time assessment of blood flow in the brain by combining robotics and artificial intelligence (AI).

Thus, owing to the aforementioned factors, the studied market is expected to grow over the forecast period.

Competitive Landscape

The market studied is moderately competitive, and there are several international as well as local companies in the market. Some of the companies that have been currently dominating the transcranial Doppler ultrasound system markets market are Neural Analytics, Viasonix, Rimed, B. Braun Melsungen AG, and Konica Minolta Healthcare India Pvt. Ltd, and Spencer Technologies.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.